Sheng Tai
- Cancer Research top 2%
- MicroRNA in disease regulation 16
- Cancer-related molecular mechanisms research 16
- Immunology top 5%
- Urology top 2%
- Urinary Bladder and Prostate Research 7
- Molecular Biology top 5%
- RNA modifications and cancer 10
- Clinical Biochemistry top 5%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 12
-
- Renal cell carcinoma treatment 10
- Prostate Cancer Diagnosis and Treatment 7
-
- Pancreatic and Hepatic Oncology Research 10
- Co-authors
- Chang Yin LiangAllan TsungHai HuangPatricia LoughranSamer TohmeJiaoti HuangWilliam OhHong Zhang
- Cited by
- Cancer ResearchImmunologyUrology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Sheng Tai
105 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Cancer Research 1.0k
- Immunology 786
- Urology 215
- Molecular Biology 1.7k
- Clinical Biochemistry 135
Countries citing papers authored by Sheng Tai
This map shows the geographic impact of Sheng Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Tai more than expected).
Fields of papers citing papers by Sheng Tai
This network shows the impact of papers produced by Sheng Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Tai. The network helps show where Sheng Tai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheng Tai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 5 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 39 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 13 | |
| 13 | 2020 | 28 | |
| 14 | 2019 | 213 | |
| 15 | 2019 | 27 | |
| 16 | 2019 | 1 | |
| 17 | 2014 | 24 | |
| 18 | 2012 | 24 | |
| 19 | 2012 | 23 | |
| 20 | 2006 | 23 |
About Sheng Tai
Sheng Tai is a scholar working on Cancer Research, Urology and Pulmonary and Respiratory Medicine, having authored 110 papers that have together received 3.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Renal cell carcinoma treatment (10 papers), Pancreatic and Hepatic Oncology Research (10 papers), RNA modifications and cancer (10 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Urinary Bladder and Prostate Research (7 papers). The work is most often cited by research in Cancer Research (1.0k citations), Immunology (786 citations) and Urology (215 citations). Sheng Tai has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Chang Yin Liang, Allan Tsung, Hai Huang, Patricia Loughran, Samer Tohme, Jiaoti Huang, William Oh, Hong Zhang, Yin Sun and Jill Squires. Their work appears in journals such as Medicine, Hepatology, Cancer Management and Research, Oncotarget and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.